XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]        
Revenue $ 728,867 $ 823,800 $ 2,208,648 $ 2,383,957
Cost of revenue (exclusive of amortization shown separately below) (387,499) (645,311) (1,297,366) (1,773,889)
Gross profit 341,368 178,489 911,282 610,068
Other income        
Government support income 173,271 83,842 433,039 346,917
Operating expenses        
Selling, general and administrative expenses (2,407,558) (2,425,830) (6,165,688) (6,587,934)
Development and regulatory approval expenses (358,351) (471,313) (1,814,047) (923,712)
Depreciation and amortization (301,978) (318,923) (907,577) (916,796)
Total operating expenses (3,067,887) (3,216,066) (8,887,312) (8,428,442)
Loss from operations (2,553,248) (2,953,735) (7,542,991) (7,471,457)
Other income (expense), net        
Interest expense (15,000) (42,674) (50,829) (112,590)
Realized foreign exchange loss (113) (996) (914) (1,551)
Fair value gain on revaluation of financial instrument 175,738
Interest income 17,687 10,640 92,464 14,288
Total other income, net 2,574 (33,030) 40,721 75,885
Net loss (2,550,674) (2,986,765) (7,502,270) (7,395,572)
Net loss attributable to non-controlling interest (7,148) (9,098) (23,641) (23,060)
Net loss attributable to Intelligent Bio Solutions Inc. (2,543,526) (2,977,667) (7,478,629) (7,372,512)
Other comprehensive income (loss), net of tax        
Foreign currency translation gain (loss) 116,007 (144,026) 189,197 (86,909)
Total other comprehensive income (loss) 116,007 (144,026) 189,197 (86,909)
Comprehensive loss (2,434,667) (3,130,791) (7,313,073) (7,482,481)
Comprehensive loss attributable to non-controlling interest (7,148) (9,098) (23,641) (23,060)
Comprehensive loss attributable to Intelligent Bio Solutions Inc. $ (2,427,519) $ (3,121,693) $ (7,289,432) $ (7,459,421)
Net loss per share, basic $ (0.44) $ (1.43) $ (1.59) $ (6.64)
Net loss per share, diluted $ (0.44) $ (1.43) $ (1.59) $ (6.64)
Weighted average shares outstanding, basic 5,771,911 2,079,864 4,698,494 1,110,089
Weighted average shares outstanding, diluted 5,771,911 2,079,864 4,698,494 1,110,089